Together with these cytokines, we found that levels of the purinergic receptor P2X7 also increase in the plasma of symptomatic COVID-19 patients, that these levels increase as the severity of the disease increases and that they correlate with the levels of the acute phase protein CRP, different cytokines and poor outcome. This evidence concerns the gene P2RX7 and COVID-19.